Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ACLC 2018
IASLC Asia Conference on Lung Cancer 2018
Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.
Presentation Date(s):- November 8 - 10, 2018
- Total Presentations: 137
-
+
Poster Session
- Type: Poster Session
- Track:
- Presentations: 90
- Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
-
+
P026 - Impact of Prior Cancer History on the Overall Survival of Younger Patients with Lung Cancer
00:00 - 00:00 | Author(s): H. Zhou
- Abstract
Loading... -
+
P038 - Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study
00:00 - 00:00 | Author(s): J. Liu
- Abstract
Loading... -
+
P040 - Highly Sensitivity and Fast Genetic Diagnosis by Mean of a Novel NGS-Based Resequencing Gene Panel Underlying SCLC Patients
00:00 - 00:00 | Author(s): J. Wang
- Abstract
Loading... -
+
P053 - The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
00:00 - 00:00 | Author(s): K. Zhang
- Abstract
Loading... -
+
P082 - DNA Methylation: A More Sensitive Marker for Treatment Monitoring?
00:00 - 00:00 | Author(s): S. Xia
- Abstract
Loading... -
+
P101 - Intratumor Heterogeneity Comparison Among Different Subtypes of
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P102 - The Correlations of Tumor Mutational Burden Among Single-region Tissue, Multi-region Tissues And Blood in NSCLC
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P115 - Clinical Outcome of Crizotinib in Diverse ALK Fusion Partners and Different Detection Methods Treatment Na
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P116 - Real World Data of 1st Line A+T in Advanced EGFR+ NSCLC: Clinical Outcome, PFS Influential Factors and Acquired Resistance
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading...
-
+
Best abstracts selected from submissions 4
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 10:50 - 11:30, Crystal Ballroom
-
+
OA07 - Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers (Slides Available)
16:50 - 17:00 | Author(s): Z. Liu
- Abstract
Loading...
-
+
Best abstracts selected from submissions 7
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Jade Ballroom
-
+
OA13 - High-dose Icotinib in Advanced NSCLC with EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study (Slides Available)
22:20 - 22:30 | Author(s): X. Li
- Abstract
Loading... -
+
OA14 - Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer (Slides Available)
22:30 - 22:40 | Author(s): Y. Cheng
- Abstract
Loading...